In October, the drug developer sent a letter to FDA official Dr. Nikolay Nikolov alleging that the CRL was "unlawful" and that the agency's review of the application was not scientifically legitimate.
Lothringer told Space.com. "We have a listing of exoplanet-related observations called TrExoLiSTS created by my collaborator ...